As TP53 mutation was associated with higher genetic instability in ALK positive NSCLC,37 we identified that the number of detected somatic mutations in cfDNA in the patients with TP53 mutations was significantly higher than those with TP53 wild type (Figure S7E). Here, TP53 is linked to non-small cell lung carcinoma.